Cargando…
Refocusing Peroxisome Proliferator Activated Receptor-α: A New Insight for Therapeutic Roles in Diabetes
Although glucose-lowering treatment shows some risk lowering effects in cardiovascular diseases, risks of macrovascular and microvascular complications have still remained, and development of new therapeutic strategies is needed. Recent data have shown that peroxisome proliferator activated receptor...
Autores principales: | Seok, Hannah, Cha, Bong Soo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Diabetes Association
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3816132/ https://www.ncbi.nlm.nih.gov/pubmed/24199160 http://dx.doi.org/10.4093/dmj.2013.37.5.326 |
Ejemplares similares
-
Role of Peroxisome Proliferator-Activated Receptor α in Diabetic Nephropathy
por: Chung, Sungjin, et al.
Publicado: (2011) -
Impact of peroxisome proliferator-activated receptor-α on diabetic cardiomyopathy
por: Wang, Lin, et al.
Publicado: (2021) -
Selective peroxisome proliferator-activated receptorα modulators (SPPARMα): The next generation of peroxisome proliferator-activated receptor α-agonists
por: Fruchart, Jean-Charles
Publicado: (2013) -
Peroxisome proliferator-activated receptor α as a novel therapeutic target for schizophrenia
por: Wada, Yuina, et al.
Publicado: (2020) -
Therapeutic targeting of ALS pathways: Refocusing an incomplete picture
por: Maragakis, Nicholas J., et al.
Publicado: (2023)